Form 4: Myriad Genetics CFO Scott Leffler Reports Stock Transactions
SEC Form 4 Filing
Scott Leffler, CFO of Myriad Genetics, reports acquisition of restricted stock units and disposition of shares to cover tax obligations.
Summary
- Scott J. Leffler, the Chief Financial Officer of Myriad Genetics Inc., filed a Form 4 detailing changes in beneficial ownership.
- On March 13, 2025, Leffler acquired 72,165 shares of common stock through time-based restricted stock units granted under the company's 2017 Employee, Director and Consultant Equity Incentive Plan.
- These restricted stock units vest in three equal annual installments starting on the first anniversary of the grant date.
- On March 14, 2025, Leffler disposed of 6,217 shares of common stock at a price of $10.07 to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Following these transactions, Leffler beneficially owns 218,393 shares of Myriad Genetics Inc.
- common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which is neutral in sentiment. It reflects routine compensation and tax-related activities.
Positives
- The acquisition of restricted stock units indicates confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.
Comparison to Industry Standards
- Monitoring insider transactions is a standard practice in financial analysis.
- Comparing Leffler's transactions to those of other CFOs in the biotech industry can provide insights into the perceived value and stability of Myriad Genetics relative to its peers.
- Companies like Exact Sciences (EXAS) and Illumina (ILMN) also have frequent insider trading activity that is closely watched by investors.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/13/2025 | Acquisition of 72,165 shares of common stock through restricted stock units. |
| 03/14/2025 | Disposition of 6,217 shares at $10.07 to cover tax obligations. |
| 03/17/2025 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.